Alto Neuroscience, Inc. (ANRO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE

Key Metrics

• Price: $19.26
• Market Cap: $589.95M
• EPS: $-2.30
• 52-Week High: $20.91
• 52-Week Low: $1.60

Market Sentiment

Alto Neuroscience, Inc. currently has a Bullish sentiment score of 0.39.

About Alto Neuroscience, Inc.

Alto Neuroscience, Inc. (ANRO) is a clinical-stage biopharmaceutical company dedicated to revolutionizing mental health care through the development of innovative therapies for psychiatric disorders. Based in Los Altos, California, the company leverages advanced neurobiological research to address unmet medical needs, showcasing a robust pipeline of proprietary drug candidates. With a strong commitment to scientific excellence, Alto Neuroscience is poised to lead the next generation of psychi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Alto Neuroscience, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ANRO pay dividends?

Alto Neuroscience, Inc. (ANRO) does not currently pay a regular dividend.

What is ANRO's market cap?

Alto Neuroscience, Inc. (ANRO) has a market capitalization of $589.95M with a current stock price of $19.26.